The agency tracks pharmacy data on COVID-19 therapeutic supplies for Merck’s antiviral molnupiravir, Pfizer’s antiviral Paxlovid and AstraZeneca’s monoclonal antibody treatment Evusheld. Medication volumes represent data as of Jan. 31 or Feb. 1, the most recent data available.
Six pharmacies with the largest supply of Merck’s antiviral:
1. Alto Pharmacy (New York City) — 11,321 courses of molnupiravir available as of Feb. 1
2. Publix Pharmacy (Fort Lauderdale, Fla.) — 3,051 courses of molnupiravir available as of Feb. 1
3. Publix Pharmacy (Miami) — 3,041 courses of molnupiravir available as of Feb. 1
4. Publix Pharmacy (Sebring, Fla.) — 3,035 courses of molnupiravir available as of Feb. 1
5. Publix Pharmacy (West Palm Beach, Fla.) — 3,025 courses of molnupiravir available as of Feb. 1
6. Publix Pharmacy (Punta Gorda, Fla.) — 3,020 courses of molnupiravir available as of Feb. 1
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
